Stock market today: Dow, S&P 500, Nasdaq stall as investors weigh earnings, Trump on China
Published On Jan 24, 2025, 1:15 PM
US stocks showed mixed results as investors processed recent earnings and President Trump's suggestion of a softer approach to China tariffs. While the major indexes like the Dow and S&P 500 made gains over the week, they struggled to maintain momentum on Friday. Trump’s comments about potentially cutting interest rates and taxes contributed to investor optimism, although concerns linger over his ability to implement these changes. Notable stock movements included Boeing's decline due to forecasted losses and Novo Nordisk's rise following positive results for a new weight-loss drug. Overall, the market is experiencing volatility with upcoming major tech earnings set to influence future movements.
Stock Forecasts
BA
Negative
Boeing faces challenges ahead with projected significant quarterly losses due to labor strikes and layoffs, which could hurt investor sentiment. Expect stock price declines as these issues weigh heavily on its financial outlook.
NVO
Positive
Novo Nordisk is gaining momentum following favorable results for its new weight-loss drug, which positions the company strong in a competitive market. The positive response from investors is likely to drive the stock higher as the product paves the way for significant revenues.
META
Positive
Meta's aggressive investment in AI development signals a commitment to innovation and potential market leadership. The substantial increase in capital expenditures could lead to further gains as tech advancements unfold. Investor confidence may trend upwards as the company reports earnings.
SPY
Neutral
The Dow Jones and S&P 500 are likely to remain in a volatile state as investors react to political statements and upcoming earnings reports. The possibility of ongoing fluctuations suggests a neutral outlook in the near-term until clearer economic signals emerge.
Related News
Novo Nordisk stock pops on phase I data for new weight-loss drug amycretin
Jan 24, 2025, 9:47 AM
Novo Nordisk announces new early clinical trial data for its latest weight loss drug, amecrytin.
Stock market today: Dow, S&P 500, Nasdaq stall as investors weigh earnings, Trump on China
Jan 24, 2025, 1:15 PM
Wall Street stocks are on track for weekly wins as markets ride the Trump roller-coaster.
Boeing sees $3.5B cash flow loss due to labor strikes and layoffs in the fourth quarter
Jan 23, 2025, 5:28 PM
Boeing reported preliminary fourth quarter results on Thursday after the bell, estimating a whopping $3.5 billion operating cash flow loss to the quarter, citing the effects of a work stoppage, workforce reductions, and changes in its defense business.